东富龙收盘上涨1.86%，滚动市盈率61.55倍，总市值92.05亿元

Group 1 - The core viewpoint of the articles highlights Dongfulong's current stock performance, with a closing price of 12.02 yuan, an increase of 1.86%, and a rolling PE ratio of 61.55 times, which is higher than the industry average of 50.80 times [1][2] - Dongfulong's total market capitalization is reported at 9.205 billion yuan, ranking 93rd in the medical device industry based on PE ratio [1][2] - The company experienced a net inflow of main funds amounting to 2.6769 million yuan on June 3, but overall, there has been a net outflow of 97,700 yuan over the past five days [1] Group 2 - Dongfulong Technology Group Co., Ltd. specializes in providing pharmaceutical process solutions, core equipment, and system engineering solutions to global pharmaceutical companies [1] - The company's main product segments include bioprocessing, formulation, engineering solutions, and food equipment engineering [1] - In the latest quarterly report for Q1 2025, Dongfulong achieved an operating revenue of 1.137 billion yuan, reflecting a year-on-year increase of 2.58%, while net profit was reported at 20.1326 million yuan, showing a significant year-on-year decline of 68.87% with a sales gross margin of 24.45% [1]